Allarity Therapeutics, Inc. (ALLR): שווי פעילות לרווח לפני ריבית, מסים ופחת

Allarity Therapeutics (ALLR) is building an adaptive delivery system for chemical components for personalized therapy, mitigating risks by partnering with various laboratories. The business model is independent of economic cycles, relying on AI solutions and collaborations with pharmaceutical leaders. This EV/EBITDA price trend chart is fixed at 0.00. The company's environmental policy is limited to standard waste disposal and energy saving in office premises.

This indicator determines operational efficiency by comparing the total enterprise value, including debt and taxes, with earnings before interest, taxes, depreciation, and amortization. For Allarity Therapeutics (ALLR), which minimizes capital expenditures through research outsourcing, this metric reveals the real value of assets relative to current cash flow, clearly reflecting the change in the EV/EBITDA multiple over time.